LONG-ACTING RECOMBINANT HUMAN GROWTH HORMONE AND USE THEREOF

Title:

LONG-ACTING RECOMBINANT HUMAN GROWTH HORMONE AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/142109

Kind Code:

A1

Abstract:

The present application relates to a fusion protein, comprising: a transferrin-binding protein, and a growth hormone or a functionally active fragment thereof. The transferrin-binding protein comprises a polypeptide, or an antibody or an antigen-binding fragment thereof capable of binding to transferrin. The present application further provides a method for preparing the fusion protein and use of the fusion protein.

More Like This:

WO/2009/072609	GENE CAPABLE OF INCREASING THE PRODUCTION OF OIL-AND-FAT IN PLANT, AND USE THEREOF
JP2012505887	Biomarkers and methods for the detection and treatment of spinal cord and joint pain
WO/2023/160260	CD7-CAR-T CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Inventors:

HAN ZHAOZHONG (CN)
PAN HONGYA (CN)
PENG MENGFAN (CN)

Application Number:

PCT/CN2022/075176

Publication Date:

August 03, 2023

Filing Date:

January 30, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

LINNO PHARMACEUTICALS INC (CN)

International Classes:

C07K19/00; A61K38/27; A61K39/395; A61P5/06; C12N5/07; C12N15/62; C12N15/63

Domestic Patent References:

WO2019074498A1	2019-04-18
WO2018004294A2	2018-01-04

Foreign References:

CN105555310A	2016-05-04
CN110054700A	2019-07-26
CN102268094A	2011-12-07

Attorney, Agent or Firm:

SHANGHAI DIANSHI PARTNERS, P.C. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: WIRELESS COMMUNICATION METHOD AND APPARATUS

Next Patent: DISPLAY SUBSTRATE AND DISPLAY APPARATUS